摘要
背景:血管危险因素和白质损害对轻度认知功能障碍(MCI)进展至痴呆症的影响的证据并不确定。 目的:该研究旨在从全球角度分析这些因素对MCI痴呆进展的影响。 方法:我们的研究包括105例MCI患者。 结果:平均随访3.09年(范围2-3.79)后,47例(44.76%)进展为痴呆:混合性痴呆32例(30.8%),可能性AD 13例(12.5%),2例(1.9%)血管性痴呆。总胆固醇水平(OR:1.015 [1.003-1.028])和LDL胆固醇水平(OR:1.018 [1.004-1.032])增加了患痴呆的风险。半胱氨酸蛋白酶抑制剂C是抵抗痴呆进展的保护因子(OR:0.119 [0.015-0.944],p = 0.044)。在第二年的随访期间,皮质下白质高信号的存在增加了痴呆进展的风险(OR:5.854 [1.008-33.846])。在第二年随访期间,皮质下和脑室周围白质高信号也与进展为痴呆的风险增加有关(OR分别为3.130 [1.098-8.922]和OR:3.561 [1.227-10.334])。沉默梗塞也是如此(OR:4.308 [1.480-12.500])。 结论:高比例的患者发展为痴呆。发现总胆固醇,低密度脂蛋白胆固醇和白质高信号与MCI进展为痴呆有关。相反,半胱氨酸蛋白酶抑制剂C被证明是防止痴呆进展的保护因子。
关键词: 轻度认知障碍,痴呆,白质高强度,血管危险因素,阿尔茨海默病,胆固醇。
Current Alzheimer Research
Title:Vascular Risk Factors and Lesions of Vascular Nature in Magnetic Resonance as Predictors of Progression to Dementia in Patients with Mild Cognitive Impairment
Volume: 15 Issue: 7
关键词: 轻度认知障碍,痴呆,白质高强度,血管危险因素,阿尔茨海默病,胆固醇。
摘要: Background: Evidence of the effect of vascular risk factors and white matter lesions on the progression of mild cognitive impairment (MCI) to dementia is not conclusive.
Objective: The study aimed to analyze the impact of these factors on MCI progression to dementia from a global perspective.
Methods: Our study included a population of 105 patients with MCI.
Results: After a mean follow-up period of 3.09 years (range, 2-3.79), 47 patients (44.76%) progressed to dementia: 32 (30.8%) to mixed dementia, 13 (12.5%) to probable AD, and 2 (1.9%) to vascular dementia. Total cholesterol levels (OR: 1.015 [1.003-1.028]) and LDL cholesterol levels (OR: 1.018 [1.004-1.032]) increased the risk of progression to dementia. Cystatin C was a protective factor against progression to dementia (OR: 0.119 [0.015-0.944], p = 0.044). During the second year of follow-up, the presence of subcortical white matter hyperintensities increased the risk of progression to dementia (OR: 5.854 [1.008- 33.846]). Subcortical and periventricular white matter hyperintensities were also associated with an increased risk of progression to dementia during the second year of follow-up (OR: 3.130 [1.098-8.922] and OR: 3.561 [1.227-10.334], respectively). The same was true for silent infarcts (OR: 4.308 [1.480- 12.500]).
Conclusion: A high percentage of patients progressed to dementia. Total cholesterol, LDL cholesterol, and white matter hyperintensities were found to be associated with MCI progression to dementia. In contrast, cystatin C was shown to be a protective factor against progression to dementia.
Export Options
About this article
Cite this article as:
Vascular Risk Factors and Lesions of Vascular Nature in Magnetic Resonance as Predictors of Progression to Dementia in Patients with Mild Cognitive Impairment, Current Alzheimer Research 2018; 15 (7) . https://dx.doi.org/10.2174/1567205015666180119100840
DOI https://dx.doi.org/10.2174/1567205015666180119100840 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of Nitric Oxide Synthase Inhibitors in Schizophrenia
Current Medicinal Chemistry The Role of Aβ Peptides in Alzheimers Disease
Protein & Peptide Letters Relevance of the Chronobiological and Non-chronobiological Actions of Melatonin for Enhancing Therapeutic Efficacy in Neurodegenerative Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Recent Advances in the Discovery of α1-Adrenoceptor Agonists
Current Topics in Medicinal Chemistry Multi-Nutrient Dietary Intervention Approach to the Management of Alzheimer’s Disease – A Mini-Review
Current Alzheimer Research Conference Report: Nanotechnology Congress & Expo 2015, Frankfurt, Germany August 11-13, 2015
CNS & Neurological Disorders - Drug Targets The Na+/H+ Exchanger: A Target for Cardiac Therapeutic Intervention
Current Drug Targets - Cardiovascular & Hematological Disorders Mechanistic Modeling of Soluble Aβ Dynamics and Target Engagement in the Brain by Anti-Aβ mAbs in Alzheimer’s Disease
Current Alzheimer Research Neuroinflammation: A Therapeutic Target of Cotinine for the Treatment of Psychiatric Disorders?
Current Pharmaceutical Design GuidAge Study: A 5-Year Double Blind, Randomised Trial of EGb 761 for the Prevention of Alzheimers Disease in Elderly Subjects with Memory Complaints. I. Rationale, Design and Baseline Data
Current Alzheimer Research The Changing Face of HIV/AIDS in Treated Patients
Current HIV Research The Effects of Soluble Aβ Oligomers on Neurodegeneration in Alzheimer's Disease
Current Pharmaceutical Design New Insights into the Roles of Endolysosomal Cathepsins in the Pathogenesis of Alzheimers Disease: Cathepsin Inhibitors as Potential Therapeutics
CNS & Neurological Disorders - Drug Targets An Outline of the Historical and Clinical Aspects of Catatonic Schizophrenia
Current Psychiatry Reviews Omega-3 Fatty Acids in the Management of Epilepsy
Current Topics in Medicinal Chemistry Pharmacological Manipulation of the Vasoconstrictive Effects of Amyloid- β Peptides by Donepezil and Rivastigmine
Current Alzheimer Research Functional Roles of Synaptic and Extrasynaptic NMDA Receptors in Physiological and Pathological Neuronal Activities
Current Drug Targets Molecular Evidence of Cryptotanshinone for Treatment and Prevention of Human Cancer
Anti-Cancer Agents in Medicinal Chemistry An Aβ Sequestration Approach Using Non-Antibody Aβ Binding Agents
Current Alzheimer Research Voxel-Based Morphometry of the Human Brain: Methods and Applications
Current Medical Imaging